Skip to main content
NewslettersWatchlist

Masimo Corp(MASI-Q)
NASDAQ

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Day Low157.55
Day High163.10
Open:161.39
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.
Select a category then submit the form to load news
Motley Fool
Why Masimo Stock Crushed the Market Today
TheNewswire.com
TOP RANKED ROSEN LAW FIRM Encourages Masimo Corporation Investors to Inquire About Securities Class Action Investigation - MASI
TheNewswire.com
NATIONALLY RANKED ROSEN LAW FIRM Encourages Masimo Corporation Investors to Inquire About Securities Class Action Investigation - MASI
TheNewswire.com
MASI LOSS ALERT: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Masimo Corporation Investors to Inquire About Securities Class Action Investigation - MASI
TheNewswire.com
MASI INVESTOR ALERT: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Masimo Corporation Investors to Inquire About Securities Class Action Investigation - MASI
TheNewswire.com
MASI INVESTOR ALERT: ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Masimo Corporation Investors to Inquire About Securities Class Action Investigation - MASI
TheNewswire.com
NATIONALLY RANKED ROSEN LAW FIRM Encourages Masimo Corporation Investors to Inquire About Securities Class Action Investigation - MASI
TheNewswire.com
ROSEN, A TOP RANKED LAW FIRM, Encourages Masimo Corporation Investors to Inquire About Securities Class Action Investigation - MASI
TheNewswire.com
ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages Masimo Corporation Investors to Inquire About Securities Class Action Investigation - MASI
TheNewswire.com
ROSEN, TOP RANKED NATIONAL INVESTOR ATTORNEYS, Encourages Masimo Corporation Investors to Inquire About Securities Class Action Investigation - MASI
TheNewswire.com
MASI LOSS ALERT: ROSEN, A RANKED AND LEADING FIRM, Encourages Masimo Corporation Investors to Inquire About Securities Class Action Investigation - MASI
Barchart
Stocks Set to Open Higher as Iran-Israel Tensions Ease, Earnings and Fed Speak in Focus
Motley Fool
How's AT&T Handling Things?
Motley Fool
Can a New CEO Fix Boeing?
Motley Fool
Boeing's Leadership Shake-Up
Barchart
Stocks Slip on Corporate News and Hawkish Fed Comments
Barchart
Negative Corporate News Undercuts Stocks
Barchart
Stocks Open Lower as Investors Await U.S. Economic Data and Fed Speak
Motley Fool
Apple's Win
Barchart
Is It Time to Take Profits on Apple Stock?
MarketBeat
Apple: A bite of reality in a volatile market
Motley Fool
Apple Pauses Watch Sale Due to Technology Dispute. What Should You Do With the Stock?

Profile

Masimo Corporation develops, manufactures and markets a family of non-invasive monitoring systems. The Company has two segments: Product Revenues, Royalty & Other revenues. Within Product revenues, the company's flagship - Signal Extraction Tecgnology (SET) Pulse Oximetry - is used to monitor blood oxygen saturation levels and protect against hypoxemia and hyperoxemia. The device also measures pulse rate. Apart from blood monitoring, the company has also ventured into non-invasive blood constituent, brain and breathe monitoring. The company's rainbow Pulse CO-Oximetry measures blood constituents that include total hemoglobin (SpHb), oxygen content (SpOC), carboxyhemoglobin (SpCO), methemoglobin (SpMet) and SET measurements of oxygen saturation (SpO2), pulse rate (PR), perfusion index (PI), and pleth variability index (PVi). Rainbow Acoustic Monitoring measures respiration rate (RRa) non-invasively and on a continuous basis. SedLine monitors brain functioning of patients under anesthesia or sedation.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2024.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2024 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.